Novel Combination 'Encouraging' in Advanced Kidney CancerNovel Combination 'Encouraging' in Advanced Kidney Cancer
An investigational antiangiogenic inhibitor of the ALK1 pathway and a VEGF inhibitor showed promising activity and a good safety profile in advanced renal cell carcinoma. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Health | Hematology | Kidney Cancer | Renal Cell Carcinoma | Urology & Nephrology